7 million Americans live with dementia, a number projected to double by 2060. Dr. Stephanie Nothelle, a Johns Hopkins geriatrician, clarifies the critical distinction between normal age-related memory lapses and dementia: "The magic line is when cognitive impairment disrupts daily function," such as failing to drive familiar routes or manage finances. This transition often signals the need for medical evaluation.**

Lewy body dementia, the second-most-common form, manifests through posture changes, shuffling gait, and slowed movement. These physical shifts—often mistaken for arthritis or clumsiness—warrant attention if persistent. Trouble walking and balancing** emerges early, requiring cognitive processing of sensory inputs like foot sensations and visual cues. Memory loss remains central, but Dr. Jori Fleisher emphasizes monitoring unexplained changes in taste, smell, or swallowing ability, which may precede other symptoms.

Aspiration pneumonia becomes a risk as dementia progresses, linked to food or fluid entering lungs during eating. Incontinence and bladder control issues arise from nerve degeneration, while sleep disturbances like REM behavior disorder—acting out dreams—can precede Parkinson’s or Lewy body dementia by years. These symptoms collectively underscore the disease’s physical toll beyond cognitive decline.

Early diagnosis leverages biomarkers in blood or spinal fluid to identify dementia types, enabling tailored treatments. While no cure exists, timely intervention manages symptoms and aids families in planning care, living arrangements, and financial decisions. Nothelle stresses: "A diagnosis and knowledge is power." Fleisher adds that research into pharmaceutical options is accelerating, making early detection increasingly vital.